Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
45.84
+0.43 (0.95%)
At close: Mar 9, 2026, 4:00 PM EDT
46.59
+0.75 (1.64%)
After-hours: Mar 9, 2026, 7:50 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $26.44 billion as of March 9, 2026. Its market cap has increased by 83.09% in one year.
Market Cap
26.44B
Enterprise Value
34.78B
1-Year Change
83.09%
Ranking
Category
Stock Price
$45.84
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $26.44B, an increase of 67.78%. That is a compound annual growth rate of 9.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 44.16B |
| Alnylam Pharmaceuticals | 42.53B |
| BeOne Medicines AG | 33.41B |
| Insmed | 30.21B |
| BioNTech SE | 25.47B |
| Moderna | 20.74B |
| Roivant Sciences | 20.60B |
| Revolution Medicines | 19.50B |